New Edge Advisors, LLC Bio N Tech Se Transaction History

New Edge Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$102.58 - $129.66 $291,840 - $368,882	-2,845 Reduced 98.61%	40 $4,000
Q1 2023 May 12, 2023	BUY	$122.57 - $153.67 $321,746 - $403,383	2,625 Added 1009.62%	2,885 $359,000
Q4 2022 Feb 14, 2023	BUY	$118.43 - $186.05 $30,791 - $48,373	260 New	260 $39,000
Q4 2021 Feb 17, 2022	SELL	$216.64 - $362.52 $348,790 - $583,657	-1,610 Closed	0 $0
Q3 2021 Oct 29, 2021	BUY	$205.93 - $447.23 $22,446 - $48,748	109 Added 7.26%	1,610 $440,000
Q2 2021 Jul 22, 2021	BUY	$113.32 - $241.49 $170,093 - $362,476	1,501 New	1,501 $336,000

364

39.6M

3.01M

2.01M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $24.1B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of New Edge Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on New Edge Advisors, LLC with notifications on news.